Difference between revisions of "Von Willebrand factor and factor VIII complex, human"
Jump to navigation
Jump to search
m |
m (Jwarner moved page Von Willebrand Factor and factor VIII complex, human to Von Willebrand factor and factor VIII complex, human: Naming convention) |
||
| (5 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | |||
| − | |||
==General information== | ==General information== | ||
Class/mechanism: Von Willebrand Factor (vWF) and coagulation factor VIII complex; allows for improved platelet function & coagulation in patients with von Willebrand Disease (vWD) and/or hemophilia A. VWF mediates binding between platelets and damaged endothelial tissue in addition to functioning as a carrier protein for factor VIII, which is a participant in the coagulation cascade.<br>Please choose from the products below to find specific drug/manufacturer information: | Class/mechanism: Von Willebrand Factor (vWF) and coagulation factor VIII complex; allows for improved platelet function & coagulation in patients with von Willebrand Disease (vWD) and/or hemophilia A. VWF mediates binding between platelets and damaged endothelial tissue in addition to functioning as a carrier protein for factor VIII, which is a participant in the coagulation cascade.<br>Please choose from the products below to find specific drug/manufacturer information: | ||
| Line 9: | Line 7: | ||
<br>Extravasation: no information | <br>Extravasation: no information | ||
| − | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. | + | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information. |
==Patient drug information== | ==Patient drug information== | ||
*[http://www.uptodate.com/contents/antihemophilic-factor-von-willebrand-factor-complex-human-patient-drug-information Von Willebrand Factor and factor VIII complex, human patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/antihemophilic-factor-von-willebrand-factor-complex-human-patient-drug-information Von Willebrand Factor and factor VIII complex, human patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/antihemophilic-factor-von-willebrand-factor-complex-human-patient-drug-information Von Willebrand Factor and factor VIII complex, human patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/antihemophilic-factor-von-willebrand-factor-complex-human-patient-drug-information Von Willebrand Factor and factor VIII complex, human patient drug information (UpToDate)]</ref> | ||
| + | |||
| + | ==Also known as== | ||
| + | *'''Generic name:''' antihemophilic factor/von Willebrand Factor complex | ||
| + | *'''Brand names:''' Alphanate, Humate-P, Wilate, Wilfactin | ||
==References== | ==References== | ||
<references/> | <references/> | ||
| − | [[Category: | + | [[Category:Fractionated plasma products]] |
| + | [[Category:Intravenous medications]] | ||
| + | |||
| + | [[Category:Inherited coagulopathy medications]] | ||
[[Category:Hematology medications]] | [[Category:Hematology medications]] | ||
[[Category:Coagulation factors]] | [[Category:Coagulation factors]] | ||
Latest revision as of 12:02, 23 August 2018
General information
Class/mechanism: Von Willebrand Factor (vWF) and coagulation factor VIII complex; allows for improved platelet function & coagulation in patients with von Willebrand Disease (vWD) and/or hemophilia A. VWF mediates binding between platelets and damaged endothelial tissue in addition to functioning as a carrier protein for factor VIII, which is a participant in the coagulation cascade.
Please choose from the products below to find specific drug/manufacturer information:
Route: IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.
Patient drug information
Also known as
- Generic name: antihemophilic factor/von Willebrand Factor complex
- Brand names: Alphanate, Humate-P, Wilate, Wilfactin
References
- ↑ Von Willebrand Factor and factor VIII complex, human (Alphanate) package insert
- ↑ Von Willebrand Factor and factor VIII complex, human (Alphanate) (locally hosted backup)
- ↑ Humate-P manufacturer's website
- ↑ Von Willebrand Factor and factor VIII complex, human (Humate-P) package insert
- ↑ Von Willebrand Factor and factor VIII complex, human (Humate-P) (locally hosted backup)
- ↑ Wilate manufacturer's website
- ↑ Von Willebrand Factor and factor VIII complex, human (Wilate) package insert
- ↑ Von Willebrand Factor and factor VIII complex, human (Wilate) (locally hosted backup)
- ↑ Von Willebrand Factor and factor VIII complex, human patient drug information (UpToDate)